Catalyst Wire Dossier Catalyst Wire Dossier

Atrasentan

atrasentan · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

22 regulatory and trial events tracked for Atrasentan, covering 2006-08-15 to 2026-07-20. Get the full timeline:

Most recent: Clinical Trial Results: Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy [Phase 2]

See pricing